Frontlight ResearchEarly access
Triple-negative breast cancer trials in United States
172 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peoplePilot Study of Bone Mineral Density Changes During Anti-PD-1 Immunotherapy
- Where
- Nashville
- Age
- 18 years and over
- People
- 25
- Run by
- Jessica Mezzanotte Sharpe
See details and how to joinNCT07555210 - Phase 2Taking peopleAtezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA)
- Where
- Boston, Chicago, Nashville, New Lenox, Orland Park, Philadelphia, San Francisco
- Age
- 18 years and over
- People
- 40
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT04434040 - No phaseTaking peoplectDNA Positive Patients Diagnosed With cT1bN0 and cT1cN0 TNBC
- Where
- Pittsburgh
- Age
- 18 years and over
- People
- 77
- Run by
- University of Pittsburgh
See details and how to joinNCT07332975 - Phase 2Taking peopleSacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
- Where
- Boston, Brewer, Chapel Hill, Charleston, Chattanooga, Chicago, Cincinnati, Columbus, Foxborough, Miami, Milford, Philadelphia, Plantation, South Weymouth, Stamford
- Age
- 18 years and over
- People
- 110
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT04468061 - Phase 2Taking peoplePreoperative Chemotherapy, Pembrolizumab and Low or High Dose RADiation in an Expansion Cohort of Node(+), Triple Negative Breast Cancer
- Where
- Chapel Hill
- Age
- 18 years and over
- People
- 32
- Run by
- UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT07276880 - Phase 2Taking peopleTamoxifen and Pegylated Liposomal Doxorubicin for the Treatment of Patients With Metastatic or Inoperable, Locally Advanced Triple Negative Breast Cancer
- Where
- Buffalo
- Age
- 18 years and over
- People
- 30
- Run by
- Roswell Park Cancer Institute
See details and how to joinNCT06434064 - Phase 1/2Taking peopleA Study of Tetrathiomolybdate (TM) Plus Capecitabine
- Where
- Indianapolis, Lebanon, New York
- Age
- 18 years to 80 years
- People
- 204
- Run by
- Dartmouth-Hitchcock Medical Center
See details and how to joinNCT06134375 - Phase 2Taking peopleHigh Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer
- Where
- Atlanta
- Age
- 18 years and over
- People
- 29
- Run by
- Emory University
See details and how to joinNCT06492759 - Phase 1Taking peopleThis is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
- Where
- Austin, TX 78758, Boston, San Antonio
- Age
- 18 years and over
- People
- 100
- Run by
- Zumutor Biologics Inc.
See details and how to joinNCT06451497 - Early phase 1Taking peoplePersonalized Dendritic Cell Vaccine Pilot for High Risk TNBC After Neoadjuvant Therapy
- Where
- Tampa
- Age
- 18 years and over
- People
- 16
- Run by
- H. Lee Moffitt Cancer Center and Research Institute
See details and how to joinNCT06435351 - No phaseTaking peopleAccess to Genetic Testing in Underserved Patients With Cancer
- Where
- Los Angeles, Rochester
- Age
- 18 years and over
- People
- 800
- Run by
- University of Southern California
See details and how to joinNCT06422455 - No phaseTaking peopleImmune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
- Where
- Jacksonville, Phoenix, Rochester
- Age
- 18 years and over
- People
- 324
- Run by
- Mayo Clinic
See details and how to joinNCT06349642 - Phase 1/2Taking peopleA Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER)
- Where
- Gainesville, Los Angeles
- Age
- 18 years to 99 years
- People
- 65
- Run by
- University of Southern California
See details and how to joinNCT04333706 - Phase 2Taking peopleOpen-label, Single Center, Single-arm, Phase 2 Study of Neoadjuvant Pembrolizumab in Combination With Carboplatin and Paclitaxel in Patients With Stage 1 cT1b-T1cN0M0 Triple Negative Breast Cancer
- Where
- Houston
- Age
- 18 years and over
- People
- 28
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06318897 - Phase 2Taking peopleInvestigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
- Where
- Allentown, Basking Ridge, Commack, Harrison, Hartford, Miami, Middletown, Montvale, New York, Norwalk, San Carlos, Uniondale
- Age
- 18 years and over
- People
- 145
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT03808337 - Phase 1Taking peopleSafety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer
- Where
- Atlanta, Honolulu, Houston, Lebanon, Milwaukee, New York, Norwalk
- Age
- 18 years and over
- People
- 70
- Run by
- OncoTherapy Science, Inc.
See details and how to joinNCT02926690 - Phase 1Taking peoplePQ203 in Advanced Malignant Tumors Including Triple Negative Breast Cancer
- Where
- Houston, San Antonio, West Valley City
- Age
- 18 years and over
- People
- 80 worldwide
- Run by
- ProteinQure Inc.
See details and how to joinNCT07190469 - Phase 2Taking peopleA Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Uniondale
- Age
- 18 years and over
- People
- 34
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT04683679 - Early phase 1Taking peopleBortezomib Followed by Pembrolizumab and Cisplatin in metTNBC
- Where
- Dallas
- Age
- 18 years and over
- People
- 20
- Run by
- Baylor Research Institute
See details and how to joinNCT04265872 - Phase 1Taking peopleDecipHER Trial - DC1 Tx for Early-Stage TNBC and ER Low Positive Breast Cancer
- Where
- Tampa
- Age
- 18 years and over
- People
- 30
- Run by
- H. Lee Moffitt Cancer Center and Research Institute
See details and how to joinNCT05504707 - Phase 1/2Taking peopleA Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer
- Where
- Atlanta, Dallas, Germantown, Los Angeles, Nashville, Norfolk, St Louis, Westwood
- Age
- 18 years and over
- People
- 100 worldwide
- Run by
- Gilead Sciences
See details and how to joinNCT06926920 - Phase 1Taking peoplePersonalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer
- Where
- Atlanta
- Age
- 18 years and over
- People
- 18
- Run by
- Emory University
See details and how to joinNCT06324240 - No phaseTaking peoplePre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer
- Where
- Philadelphia
- Age
- 40 years and over
- People
- 80
- Run by
- Thomas Jefferson University
See details and how to joinNCT04959474 - Early phase 1Taking peopleNeoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer
- Where
- Stony Brook
- Age
- 18 years and over
- People
- 30
- Run by
- Alison Stopeck
See details and how to joinNCT06220214 - Phase 1/2Taking peopleJAB-2485 Activity in Adult Patients With Advanced Solid Tumors
- Where
- Dallas, Detroit, Salt Lake City, St Louis
- Age
- 18 years and over
- People
- 102 worldwide
- Run by
- Jacobio Pharmaceuticals Co., Ltd.
See details and how to joinNCT05490472